# Combined Haploidentical-Cord Blood Transplantation for Adults and Children

> **NCT00943800** · NA · COMPLETED · sponsor: **University of Chicago** · enrollment: 87 (actual)

## Conditions studied

- Leukemia
- Myelodysplastic Syndrome
- Multiple Myeloma
- Lymphoma

## Interventions

- **DRUG:** Fludarabine-Melphalan & Rabbit antithymocyte globulin (r-ATG)
- **PROCEDURE:** Stem Cell Transplant
- **PROCEDURE:** Stem Cells Collections
- **DRUG:** Fludarabine, Thiotepa, Antithymocyte globulin (ATG), and Total Body Irradiation (TBI)
- **DRUG:** Fludarabine, Busulfan, and ATG

## Key facts

- **NCT ID:** NCT00943800
- **Lead sponsor:** University of Chicago
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10-09
- **Primary completion:** 2018-09
- **Final completion:** 2018-09
- **Target enrollment:** 87 (ACTUAL)
- **Last updated:** 2021-01-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00943800

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00943800, "Combined Haploidentical-Cord Blood Transplantation for Adults and Children". Retrieved via AI Analytics 2026-09-09 from https://api.ai-analytics.org/clinical/NCT00943800. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*